Cited by 180Probiotics and Fermented FoodsGut microbiota and healthGastrointestinal motility and disorders

Lactobacillus fermentum (PCC®) supplementation and gastrointestinal and respiratory-tract illness symptoms: a randomised control trial in athletes

Open access
West, Nicholas P, Pyne, David B, Cripps, Allan W, Hopkins, William G, Eskesen, Dorte C, Jairath, Ashok, Christophersen, Claus T, Conlon, Michael A +1 more·2011·Nutrition Journal

Abstract

Background: Probiotics purportedly reduce symptoms of gastrointestinal and upper respiratory-tract illness by modulating commensal microflora. Preventing and reducing symptoms of respiratory and gastrointestinal illness are the primary reason that dietary supplementation with probiotics are becoming increasingly popular with healthy active individuals. There is a paucity of data regarding the effectiveness of probiotics in this cohort. The aim of this study was to evaluate the effectiveness of a probiotic on faecal microbiology, self-reported illness symptoms and immunity in healthy well trained individuals. Methods: Competitive cyclists (64 males and 35 females; age 35 ± 9 and 36 ± 9 y, VO 2 max 56 ± 6 and 52 ± 6 ml.kg-1.min-1, mean ± SD) were randomised to either probiotic (minimum 1 × 10 9 Lactobacillus fermentum (PCC®) per day) or placebo treatment for 11 weeks in a double-blind, randomised, controlled trial. The outcome measures were faecal L. fermentum counts, self-reported symptoms of illness and serum cytokines. Results: Lactobacillus numbers increased 7.7-fold (90% confidence limits 2.1- to 28-fold) more in males on the probiotic, while there was an unclear 2.2-fold (0.2- to 18-fold) increase in females taking the probiotic. The number and duration of mild gastrointestinal symptoms were ~2-fold greater in the probiotic group. However, there was a substantial 0.7 (0.2 to 1.2) of a scale step reduction in the severity of gastrointestinal illness at the mean training load in males, which became more pronounced as training load increased. The load (duration×severity) of lower respiratory illness symptoms was less by a factor of 0.31 (99%CI; 0.07 to 0.96) in males taking the probiotic compared with placebo but increased by a factor of 2.2 (0.41 to 27) in females. Differences in use of cold and flu medication mirrored these symptoms. The observed effects on URTI had too much uncertainty for a decisive outcome. There were clear reductions in the magnitude of acute exercise-induced changes in some cytokines. Conclusion: L. fermentum may be a useful nutritional adjunct for healthy exercising males. However, uncertainty in the effects of supplementation on URTI and on symptoms in females needs to be resolved. Trial registration: The trial was registered in the Australia and New Zealand Clinical Trials Registry (ACTRN12611000006943).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1475-2891-10-30

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In 80 competitive cyclists, 11 weeks of supplementation with L. fermentum (PCC®) had no effect on peak power or VO2 max.

    “Similarly, in 80 competitive cyclists, 11 weeks of supplementation with L. fermentum (PCC®) had no effect on peak power or VO2 max [61].”
  • The single strain interventions used in five studies did not produce an aerobic performance benefit.

    “The single strain interventions used in these five studies did not produce an aerobic performance benefit.”
  • In an athletic population, specific probiotic strains can reduce the number of episodes, severity and duration of upper respiratory tract infections.

    “In an athletic population, specific probiotic strains can reduce the number of episodes, severity and duration of upper respiratory tract infections.”
  • In competitive cyclists, L. fermentum (PCC®) over an 11-week winter training period reduced severity of self-reported symptoms of lower respiratory illness and use of cold and flu medication compared to placebo, but this effect was only noted in males and not females.

    “In competitive cyclists, West et al. [61] reported reduced severity of self-reported symptoms of lower respiratory illness and use of cold and flu medication over an 11-week winter training period with L. fermentum (PCC®) compared to placebo. Interestingly, this effect was only noted in males and not females.”
  • There is some limited evidence that discrepancies exist between males and females, even after supplementation of probiotics with the same dose.

    “Finally, there is some limited evidence that discrepancies exist between males and females, even after supplementation of probiotics with the same dose [61].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 45 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
West, N. P., Pyne, D. B., Cripps, A. W., Hopkins, W. G., Eskesen, D. C., Jairath, A., Christophersen, C. T., Conlon, M. A., & Fricker, P. A.
Affiliations
  • Griffith University (AU)
  • Australian National University (AU)
  • Chr. Hansen (Denmark) (DK)
  • Procomcure Biotech (Austria) (AT)
  • Commonwealth Scientific and Industrial Research Organisation (AU)
Corresponding author
Cripps, Allan W
Venue
Nutrition Journal
Published
2011-04-11
Volume
10
Issue
1
Pages
30-30
ISSN
1475-2891 (ISSN-L)
OpenAlex
W2104181007
Cited by
180
References
45
Citations by year
2026: 6 · 2025: 11 · 2024: 11 · 2023: 6 · 2022: 19 · 2021: 24 · 2020: 9 · 2019: 16 · 2018: 16 · 2017: 12 · 2016: 11 · 2015: 8 · 2014: 5 · 2013: 14 · 2012: 11
FWCI
14.49
Type
journal article
Language
en
Open access
Locations
  • Nutrition Journal (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Victoria University Research Repository (Victoria University) (submittedVersion, cc-by)
  • Griffith Research Online (submittedVersion, cc-by)
  • University of Canberra Research Portal (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • eSpace (Curtin University) (submittedVersion, cc-by)
  • ANU Open Research (Australian National University) (submittedVersion)
Funders
Australian Institute of Sport
Topics
  • Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
Keywords
Lactobacillus fermentum, probiotics, athletes, cyclists, gastrointestinal diseases, upper respiratory tract infection, fecal microbiota, serum cytokines, sex differences, training load, dietary supplementation, gut microbiota modulation, gastrointestinal symptoms, cold and flu
MeSH terms
Adult, Double-Blind Method, Feces, Female, Gastrointestinal Diseases, Humans, Immunity, Male, Middle Aged, New Zealand, Respiratory Tract Infections, Exercise, Cytokines, Probiotics, Gastrointestinal Tract, Limosilactobacillus fermentum, Young Adult, Athletes, Self Report

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review